{"id":91077,"date":"2026-05-19T17:12:35","date_gmt":"2026-05-19T11:42:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=91077"},"modified":"2026-05-19T17:12:37","modified_gmt":"2026-05-19T11:42:37","slug":"bharat-parenterals-limited-q4-fy26-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/","title":{"rendered":"Bharat Parenterals Limited Q4 FY26 Results: Loss Rs 8.16 Cr, Revenue Rs 99.62 Crore"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p><strong><a href=\"https:\/\/univest.in\/user\/stocks\/bplpharma\/bharat-parenterals-ltd-share-price-today\">Bharat Parenterals Limited<\/a> Q4 FY26<\/strong> results were declared on May 18, 2026, at the board of directors meeting. Bharat Parenterals Limited reported net loss of Rs 8.16 crore for the quarter ended March 31, 2026, Q4 FY26 (results declared May 18, 2026), on revenue of Rs 99.62 crore. Bharat Parenterals Limited operates in the intravenous fluids and pharmaceutical packaging sector. Investors tracking Bharat Parenterals Limited Q4 FY26 will find complete financial analysis and FY27 outlook in this article.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#Bharat_Parenterals_Limited_Q4_FY26_Financial_Highlights\" title=\"Bharat Parenterals Limited Q4 FY26 Financial Highlights\">Bharat Parenterals Limited Q4 FY26 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#Bharat_Parenterals_Limited_Q4_FY26_Performance_Analysis\" title=\"Bharat Parenterals Limited Q4 FY26 Performance Analysis\">Bharat Parenterals Limited Q4 FY26 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#Key_Factors_for_the_company\" title=\"Key Factors for the company\">Key Factors for the company<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#Revenue_and_Sector_Dynamics\" title=\"Revenue and Sector Dynamics\">Revenue and Sector Dynamics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#Profitability_and_Margin_Trends\" title=\"Profitability and Margin Trends\">Profitability and Margin Trends<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#FY27_Business_Outlook\" title=\"FY27 Business Outlook\">FY27 Business Outlook<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#Frequently_Asked_Questions_on_Bharat\" title=\"Frequently Asked Questions on Bharat\">Frequently Asked Questions on Bharat<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#What_is_the_company_PAT\" title=\"What is the company PAT?\">What is the company PAT?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#What_is_the_company_revenue\" title=\"What is the company revenue?\">What is the company revenue?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#When_were_Bharat_results_announced\" title=\"When were Bharat results announced?\">When were Bharat results announced?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/bharat-parenterals-limited-q4-fy26-results\/#Is_Bharat_Parenterals_Limited_a_good_investment_after_Q4_FY26\" title=\"Is Bharat Parenterals Limited a good investment after Q4 FY26?\">Is Bharat Parenterals Limited a good investment after Q4 FY26?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Bharat_Parenterals_Limited_Q4_FY26_Financial_Highlights\"><\/span><strong>Bharat Parenterals Limited Q4 FY26 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26<\/th>\n<th>Comparison<\/th>\n<\/tr>\n<tr>\n<td><strong>Net Loss<\/strong><\/td>\n<td>Rs 8.16 crore<\/td>\n<td>Q4 FY26 (results declared May 18, 2026)<\/td>\n<\/tr>\n<tr>\n<td><strong>Revenue from Operations<\/strong><\/td>\n<td>Rs 99.62 crore<\/td>\n<td>Quarter ended March 31, 2026<\/td>\n<\/tr>\n<tr>\n<td><strong>Ticker<\/strong><\/td>\n<td><\/td>\n<td>Sector: IV Fluids<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Bharat_Parenterals_Limited_Q4_FY26_Performance_Analysis\"><\/span><strong>Bharat Parenterals Limited Q4 FY26 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bharat Parenterals Limited Q4 FY26 reflects the company&#8217;s operational performance during the January to March 2026 quarter. Bharat Parenterals Limited is a leading intravenous fluids and pharmaceutical packaging company whose Q4 FY26 print sets the baseline for FY27 guidance. The reported loss reflects ongoing challenges; management guidance on FY27 recovery trajectory will be the key watchpoint. Q4 January to March is typically a seasonally strong quarter for Indian companies driven by year-end government procurement and project completion cycles.<\/p>\n<p>The path to profitability in FY27 depends on volume recovery, cost reduction, and strategic business initiatives. Track Bharat Parenterals Limited on the Univest Screener for live data.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_for_the_company\"><\/span><strong>Key Factors for the company<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_and_Sector_Dynamics\"><\/span><strong>Revenue and Sector Dynamics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Bharat revenue of Rs 99.62 crore reflects the company&#8217;s execution in the intravenous fluids and pharmaceutical packaging space. India&#8217;s sustained economic growth of 6.5%+ and robust domestic demand across sectors provide a supportive backdrop for FY27 business planning.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_and_Margin_Trends\"><\/span><strong>Profitability and Margin Trends<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The company net loss of Rs 8.16 crore Q4 FY26 (results declared May 18, 2026) demonstrates near-term margin challenges. The company&#8217;s FY27 strategy to restore profitability through volume growth and cost optimisation will be closely monitored by investors.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Business_Outlook\"><\/span><strong>FY27 Business Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Following the firm results, management guidance on FY27 revenue, order book, and strategic priorities will be key catalysts. Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to receive SEBI-registered analyst research on Bharat Parenterals Limited.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Bharat\"><\/span><strong>Frequently Asked Questions on Bharat<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_company_PAT\"><\/span><strong>What is the company PAT?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bharat reported net loss of Rs 8.16 crore Q4 FY26 (results declared May 18, 2026). Results declared May 18, 2026. Full details from NSE\/BSE regulatory filings. Verify all data before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_company_revenue\"><\/span><strong>What is the company revenue?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong style=\"color: initial;\">Ans.<\/strong><span style=\"color: initial;\"> The firm&#8217;s revenue from operations was Rs 99.62 crore for the quarter ended March 31, 2026.<\/span>\u00a0Track live on the Univest Screener.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Bharat_results_announced\"><\/span><strong>When were Bharat results announced?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company results were announced on May 18, 2026, at the board meeting approving audited Q4 and FY26 financial statements for the year ended March 31, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Bharat_Parenterals_Limited_a_good_investment_after_Q4_FY26\"><\/span><strong>Is Bharat Parenterals Limited a good investment after Q4 FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investment decisions require individual assessment of fundamentals, valuation, sector dynamics, and personal risk tolerance. This article does not constitute investment advice. Consult a SEBI-registered financial advisor before investing.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bharat Parenterals Limited Q4 FY26 results May 18 2026. net loss of Rs 8.16 crore Q4 FY26 (results declared May 18, 2026). Revenue Rs 99.62 crore. Full analysis<\/p>\n","protected":false},"author":26,"featured_media":91776,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-91077","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779190979:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["78"],"rank_math_focus_keyword":["Bharat Parenterals Limited Q4"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["91776"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["12340"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/19171201\/Bharat-Parenterals-Limited-Q4-FY26-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=91077"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91077\/revisions"}],"predecessor-version":[{"id":91777,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/91077\/revisions\/91777"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/91776"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=91077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=91077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=91077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}